Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Woosuk University, Wanju, 55338, Republic of Korea.
Nat Commun. 2024 Feb 26;15(1):1739. doi: 10.1038/s41467-024-45466-x.
Innate immunity provides the first line of defense through multiple mechanisms, including pyrogen production and cell death. While elevated body temperature during infection is beneficial to clear pathogens, heat stress (HS) can lead to inflammation and pathology. Links between pathogen exposure, HS, cytokine release, and inflammation have been observed, but fundamental innate immune mechanisms driving pathology during pathogen exposure and HS remain unclear. Here, we use multiple genetic approaches to elucidate innate immune pathways in infection or LPS and HS models. Our results show that bacteria and LPS robustly increase inflammatory cell death during HS that is dependent on caspase-1, caspase-11, caspase-8, and RIPK3 through the PANoptosis pathway. Caspase-7 also contributes to PANoptosis in this context. Furthermore, NINJ1 is an important executioner of this cell death to release inflammatory molecules, independent of other pore-forming executioner proteins, gasdermin D, gasdermin E, and MLKL. In an in vivo HS model, mortality is reduced by deleting NINJ1 and fully rescued by deleting key PANoptosis molecules. Our findings suggest that therapeutic strategies blocking NINJ1 or its upstream regulators to prevent PANoptosis may reduce the release of inflammatory mediators and benefit patients.
先天免疫通过多种机制提供第一道防线,包括发热和细胞死亡。虽然感染时体温升高有利于清除病原体,但热应激 (HS) 可导致炎症和病理损伤。已经观察到病原体暴露、HS、细胞因子释放和炎症之间存在联系,但在病原体暴露和 HS 期间驱动病理的基本先天免疫机制仍不清楚。在这里,我们使用多种遗传方法来阐明感染或 LPS 和 HS 模型中的先天免疫途径。我们的结果表明,细菌和 LPS 在 HS 期间强烈增加炎症性细胞死亡,这依赖于半胱天冬酶-1、半胱天冬酶-11、半胱天冬酶-8 和 RIPK3 通过 PANoptosis 途径。半胱天冬酶-7 在这种情况下也有助于 PANoptosis。此外,NINJ1 是释放炎症分子的重要执行者,独立于其他形成孔的执行者蛋白、gasdermin D、gasdermin E 和 MLKL。在 HS 体内模型中,通过删除 NINJ1 可降低死亡率,并通过删除关键 PANoptosis 分子完全挽救。我们的研究结果表明,阻断 NINJ1 或其上游调节剂以防止 PANoptosis 的治疗策略可能会减少炎症介质的释放并使患者受益。